| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Ecommerce > Ecommerce - The Stats Tell A Story |
|
Digg It - Ecommerce - The Stats Tell A Story
According to U.S. Government reports ecommerce continues to improve dramatically, “Total e-commerce sales for 2006 were estima According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ted at $108.7 billion, an increase of 23.5 percent (±3.3%) from 2005.” This is not surprising when you consider that 60% of a ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ll new small businesses have an online presence. This is further enhanced when you take into account the meteoric rise of onli lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ne users. In 2001 there were approximately 142 million online users. By 2006 there were approximately 211 million online users here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe (many of whom enjoy not fighting traffic to find the products they want). Online spending increased among all user groups fr d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro om 2001-2005. It is anticipated that an online consumer will spend in excess of $800 with an ecommerce business this year. Wh ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc at makes this statistic all the more remarkable is that if you have an online business presence you gain access to a marketpla easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi e with 211 million potential customers who may be willing to spend money with your online business. It may be that you are lo nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically oking at $800 per online consumer and thinking, “That’s not nearly as much as I thought.” It is true that at the present time and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ individuals will spend more in traditional brick and mortar stores than they will online, but the bigger picture has to do wit ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi h a potential customer base that is global in scale. Each individual customer may spend less with you than they might in a tra ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ditional store environment, but you have so many more potential customers to market to. Long story short, you have the capabi dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod lity of tapping into a revenue stream that is unavailable in more brick and mortar stores. Why do you think some of the large cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin st box stores develop an online presence? It is a cost effective way to manage a global customer base. It allows these large r tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen tailers to fill in the gaps where their retail presence is not available. In essence these larger stores are finding their on t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel line stores to function as a high tech catalogue. Where once catalogues were rushed to homes throughout the US, now they are o ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ften sent only on request with a large portion of their customers perusing their online offerings for the most recent offering y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products s, size and price. It’s clear to see the growth of online sales can level the playing field for ecommerce stores. Your locati . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de on on the web is only limited to your willingness to work at Search Engine Optimization (SEO) strategies and other marketing e elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip fforts. In the end, the use of an online store is an effective way to manage business in a competitive and global environment tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Nothing Ventured - Nothing Gained! Business Credit- How Much Does Your Company Need? Affiliate Tip - Remember Your Logins
|